GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Upper GI Tract/Distinct Atopic Endotypes Identified in Paediatric and Adult EoE : Frontline Gastroenterol | 2026
17

Distinct Atopic Endotypes Identified in Paediatric and Adult EoE : Frontline Gastroenterol | 2026

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated May 1, 2026

Introduction

Eosinophilic oesophagitis is an increasingly recognized type 2 inflammatory disorder characterized by oesophageal eosinophilia, dysphagia and food-related symptoms. Although EoE occurs across all age groups, differences in immunologic drivers and clinical phenotype between paediatric-onset and adult-onset disease remain incompletely understood.

Problem Statement

Current management strategies for EoE are largely uniform across age groups despite growing evidence suggesting biologic heterogeneity. Clarifying whether paediatric-onset and adult-onset EoE represent distinct atopic endotypes could improve diagnostic evaluation, allergen assessment and personalized therapeutic approaches.

Summary

This large population-based cohort study demonstrates that paediatric-onset and adult-onset EoE possess clearly distinct atopic and clinical profiles, supporting the concept of divergent disease endotypes. Paediatric-onset EoE was strongly associated with systemic allergic disease, particularly asthma, atopic dermatitis and food allergy, alongside higher peripheral eosinophil counts. These findings support a predominantly food antigen–driven inflammatory phenotype with broader systemic type 2 immune activation in younger patients. In contrast, adult-onset EoE showed stronger associations with allergic rhinitis and nasal polyposis, suggesting greater involvement of aeroallergen sensitization and upper airway allergic inflammation. The persistence of these findings after matched analysis reinforces that these differences are unlikely to be explained solely by demographic variation. The study highlights that EoE may evolve through distinct immunologic pathways depending on age at onset, potentially explaining differences in symptom presentation, trigger profiles and treatment responsiveness observed in clinical practice. Recognition of these divergent endotypes may have important implications for allergy testing, dietary therapy selection and biologic treatment strategies. The findings also support closer integration between gastroenterology, allergy and airway disease management, particularly in patients with overlapping atopic disorders. Overall, the study advances understanding of EoE heterogeneity and strengthens the rationale for precision medicine approaches tailored to age-specific inflammatory mechanisms.

Related Q&A

18

FOXM1 Blockade Restores Epithelial Homeostasis in EoE : Gut | 2026

Introduction Eosinophilic oesophagitis (EoE) is a chronic Th2-mediated inflammatory disease characterized by epithelial barrier dysfunction, basal cell hyperplasia and persistent mucosal remodeling. Even after inflammatory control, epithelial transcriptomic...

19

Exclusive Enteral Nutrition Shows Modest but Meaningful Benefit in Adult Crohn’s Disease | Indian Journal of Gastroenterology

Introduction Exclusive enteral nutrition (EEN) is a well-established induction therapy in pediatric Crohn’s disease, where it offers anti-inflammatory efficacy while avoiding corticosteroid-related toxicity. In adults, however, EEN has...

20

Rome V Gastroduodenal Disorders: Gastroenterology | May 2026

The Rome V Gastroduodenal Disorders chapter introduces several important conceptual, diagnostic, and therapeutic refinements across functional dyspepsia (FD), nausea/vomiting disorders, belching disorders, inability to belch syndrome, and rumination...

21

Rome V Pediatric Upper Gastrointestinal Disorders: Gastroenterology | May 2026

Rome V substantially expands pediatric upper gastrointestinal disorders of gut–brain interaction (DGBI), moving beyond the narrower Rome IV framework to include pediatric esophageal pain disorders, esophageal air-transit disorders,...

22

Rome V Functional Esophageal Disorders: Gastroenterology | May 2026

Rome V reframes functional esophageal disorders as esophageal disorders of gut–brain interaction (E-DGBI), emphasizing that these syndromes arise from altered esophageal sensory signaling and central perceptual processing rather...

23

Achalasia and Oesophagal Cancer: Gastroenterology | May 2026

Introduction Achalasia is a chronic oesophagal motility disorder characterised by impaired lower oesophagal sphincter relaxation and food stasis. Long-standing stasis, bacterial overgrowth, and chronic inflammation have raised concerns...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer